CD57 Test in Lyme Disease: Useful or Unreliable?
The CD57 test in Lyme disease — what it measures, Dr. Stricker's original hypothesis, conflicting study results, and how clinicians actually use it in practice.
Infectiology
Moderate EvidenceChronic Borrelia infection — diagnosis, treatment, and the persistent disease controversy.
The CD57 test in Lyme disease — what it measures, Dr. Stricker's original hypothesis, conflicting study results, and how clinicians actually use it in practice.
How the iSpot Lyme (ELISpot) T-cell test works, its advantages over antibody testing, 84% sensitivity data, limitations, and when it adds clinical value.
Why Lyme disease tests come back negative in patients with active infection. ELISA sensitivity gaps, antibody window, seronegative Lyme, and what to do when tests miss.
How Lyme disease disrupts the gut microbiome. Antibiotic-driven dysbiosis, Borrelia's effect on intestinal permeability, the Hopkins microbiome findings, and recovery strategies.
Head-to-head comparison of Western Blot and ELISA for Lyme disease. Sensitivity at each stage, what the bands mean, the two-tier protocol, and why the system misses patients.
Why St. George Hospital uses 2 extreme hyperthermia sessions at 41.6-41.8°C for Lyme eradication, not 5-6 moderate sessions. The science behind the protocol.
Honest guide to whole-body hyperthermia side effects. What happens during treatment, common reactions, Herxheimer responses, recovery timeline, and contraindications.
Whole body hyperthermia treatment explained by a physician. How controlled fever therapy works for Lyme, cancer, and post-COVID at St. George Hospital.
How bacterial biofilms reduce antibiotic efficacy by 100-1,000x, why standard treatment courses miss persistent infections, and what integrative approaches add.
A clinical overview of biofilm disruption strategies for persistent Lyme disease — the three-phase approach of disrupt, kill, and clear.
A direct comparison of American IDSA Lyme guidelines and German integrative Lyme treatment. Why patients travel to Germany, what's different, and what the evidence supports.
Does a Herxheimer reaction mean treatment is working? The science behind die-off, why worse does not always mean better, and the goal of controlled pathogen clearance.
Evidence-based strategies for managing Jarisch-Herxheimer reactions during Lyme treatment — hydration, detox support, dose pacing, and when to call your doctor.
A clinical framework for distinguishing Jarisch-Herxheimer reactions from disease flares in Lyme treatment — timing, symptom patterns, and when to act.
Why HHV-6 reactivates in virtually all chronic Lyme patients, its contribution to neurological symptoms, and testing and treatment approaches.
How Borrelia invades the central nervous system, why neuroborreliosis is underdiagnosed, and how hyperthermia, TPS, and multimodal protocols treat what antibiotics alone cannot reach.
The immune suppression cascade: how Lyme disease triggers EBV, HHV-6, and CMV reactivation, and how these viruses further suppress immunity in a vicious cycle.
Comprehensive Lyme disease symptom checklist covering neurological, musculoskeletal, cardiac, psychiatric, and GI manifestations. Based on treating 12,000+ Lyme patients at Klinik St. Georg.
Everything international patients need to know about medical treatment in Germany. Visa, costs, insurance, travel logistics, and what to expect at Klinik St. Georg in Bad Aibling — based on treating patients from 90+ countries.
Brain fog treatment options from neuroinflammation workup to neuromodulation. Causes include post-COVID, Lyme, MCAS, and mold. TPS, NAD+, and hyperbaric oxygen covered.
What to expect during brain fog recovery after Lyme treatment — the multi-system recovery approach, realistic timelines, and evidence-based strategies.
What causes brain fog in Lyme disease — Johns Hopkins PET scan findings showing glial activation, neuroinflammation mechanisms, and treatment implications.
How neurofeedback retrains dysregulated brainwave patterns in Lyme disease patients. qEEG findings, clinical evidence, and what to expect from treatment.
How pulsed electromagnetic field therapy supports pain relief and inflammation reduction in Lyme disease — mechanism, clinical evidence, and practical considerations.
How LL-37 disrupts Borrelia biofilms in chronic Lyme disease. Mechanism, preclinical evidence, protocol context, and clinical observations.
Why standard Lyme disease tests miss infections, and which advanced tests provide accurate results. ELISpot, CD57, and beyond.
What conventional medicine gets wrong about chronic Lyme disease, why standard treatment fails some patients, and our integrative approach.
Why international patients seek Lyme disease treatment in Germany. Medical culture, treatment options, and what makes the German approach different.
How Dr. Julian Douwes uses peptides in chronic Lyme disease treatment. Thymosin alpha-1, LL-37, BPC-157 protocols alongside standard Lyme therapy.
A supplement and lifestyle protocol for Lyme disease patients between clinical treatments. Evidence levels included. By Dr. Julian Douwes.